A new report issued by the National Academy of Sciences says U.S. regulatory agencies need to prepare for new plants, animals, and microbes that will be hitting the market in the next five to 10 years. The new products, the report says, could overwhelm regulatory agencies like the U.S. Department of Agriculture and Food and Drug Administration. [Here are 5.]
…
Living bacteria that act like drugs. [Scientists are developing] genetically engineered bacteria to treat a whole range of medical conditions, from cancer to metabolic disease.
Gene-edited animals and crops. [S]o far, gene-edited foods haven’t been subject to regulation because they don’t contain foreign DNA.
Lab-grown meat. Lab-grown meat represents a more environmentally and ethically friendly way to produce food, but it’s unclear how these products would be regulated.
Fragrant moss. [P]plants that appeal to consumers, perhaps for their aesthetics or novelty, are also likely to become more common…
Gene drives. A powerful technique that promotes an engineered gene’s spread through an entire population is being considered to eliminate invasive rodents on islands and to wipe out mosquitoes that transmit malaria.
The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: 5 Biotech Products U.S. Regulators Aren’t Ready For
